|
1
|
Cen L, Carlson BL, Pokorny JL, et al:
Efficacy of protracted temozolomide dosing is limited in MGMT
unmethylated GBM xenograft models. Neuro Oncol. 15:735–746. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang G, Li LT, Xin Y, Zhang L, Liu YQ and
Zheng JN: Strategies to improve the killing of tumors using
temozolomide: targeting the DNA repair protein MGMT. Curr Med Chem.
19:3886–3892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Stevens MF and Bradshaw TD:
Temozolomide: Mechanisms of action, repair and resistance. Curr Mol
Pharmacol. 5:102–114. 2012. View Article : Google Scholar
|
|
4
|
Skiriute D, Vaitkiene P, Saferis V, et al:
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in
glioblastoma. BMC Cancer. 12:2182012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Felsberg J, Thon N, Eigenbrod S, et al:
Promoter methylation and expression of MGMT and the DNA mismatch
repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and
recurrent glioblastomas. Int J Cancer. 129:659–670. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin CJ, Lee CC, Shih YL, et al:
Resveratrol enhances the therapeutic effect of temozolomide against
malignant glioma in vitro and in vivo by inhibiting autophagy. Free
Radic Biol Med. 52:377–391. 2012. View Article : Google Scholar
|
|
7
|
Katayama M, Kawaguchi T, Berger MS and
Pieper RO: DNA damaging agent-induced autophagy produces a
cytoprotective adenosine triphosphate surge in malignant glioma
cells. Cell Death Differ. 14:548–558. 2007. View Article : Google Scholar
|
|
8
|
Natsumeda M, Aoki H, Miyahara H, et al:
Induction of autophagy in temozolomide treated malignant gliomas.
Neuropathology. 31:486–493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong PM, Puente C, Ganley IG and Jiang X:
The ULK1 complex: sensing nutrient signals for autophagy
activation. Autophagy. 9:124–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
She C, Zhu LQ, Zhen YF, Wang XD and Dong
QR: Activation of AMPK protects against hydrogen peroxide-induced
osteoblast apoptosis through autophagy induction and NADPH
maintenance: New implications for osteonecrosis treatment? Cell
Signal. 26:1–8. 2014. View Article : Google Scholar
|
|
11
|
Singh K, Matsuyama S, Drazba JA and
Almasan A: Autophagy-dependent senescence in response to DNA damage
and chronic apoptotic stress. Autophagy. 8:236–251. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duan X, Ponomareva L, Veeranki S and
Choubey D: IFI16 induction by glucose restriction in human
fibroblasts contributes to autophagy through activation of the
ATM/AMPK/p53 pathway. PLoS One. 6:e195322011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brieger A, Adam R, Passmann S, Plotz G,
Zeuzem S and Trojan J: A CRM1-dependent nuclear export pathway is
involved in the regulation of MutLalpha subcellular localization.
Genes Chromosomes Cancer. 50:59–70. 2011. View Article : Google Scholar
|
|
14
|
Takahashi A and Ohnishi T: Does gammaH2AX
foci formation depend on the presence of DNA double strand breaks?
Cancer Lett. 229:171–179. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murrow L and Debnath J: Autophagy as a
stress-response and quality-control mechanism: Implications for
cell injury and human disease. Annu Rev Pathol. 8:105–137. 2013.
View Article : Google Scholar
|
|
16
|
Wu J, Dang Y, Su W, et al: Molecular
cloning and characterization of rat LC3A and LC3B - two novel
markers of autophagosome. Biochem Biophys Res Commun. 339:437–442.
2006. View Article : Google Scholar
|
|
17
|
Zeng X and Kinsella TJ: BNIP3 is essential
for mediating 6-thio-guanine- and 5-fluorouracil-induced autophagy
following DNA mismatch repair processing. Cell Res. 20:665–675.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng X and Kinsella TJ: Mammalian target
of rapamycin and S6 kinase 1 positively regulate
6-thioguanine-induced autophagy. Cancer Res. 68:2384–2390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng X and Kinsella TJ: A novel role for
DNA mismatch repair and the autophagic processing of chemotherapy
drugs in human tumor cells. Autophagy. 3:368–370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Johnson JR, Erdeniz N, Nguyen M, Dudley S
and Liskay RM: Conservation of functional asymmetry in the
mammalian MutLalpha ATPase. DNA Repair (Amst). 9:1209–1213. 2010.
View Article : Google Scholar
|
|
21
|
Polosina YY and Cupples CG: MutL:
conducting the cell’s response to mismatched and misaligned DNA.
Bioessays. 32:51–59. 2010. View Article : Google Scholar
|
|
22
|
Chahwan R, van Oers JM, Avdievich E, et
al: The ATPase activity of MLH1 is required to orchestrate DNA
double-strand breaks and end processing during class switch
recombination. J Exp Med. 209:671–678. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Quiros S, Roos WP and Kaina B: Processing
of O6-methylguanine into DNA double-strand breaks requires two
rounds of replication whereas apoptosis is also induced in
subsequent cell cycles. Cell Cycle. 9:168–178. 2010. View Article : Google Scholar
|
|
24
|
Sarkaria JN, Kitange GJ, James CD, et al:
Mechanisms of chemoresistance to alkylating agents in malignant
glioma. Clin Cancer Res. 14:2900–2908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taverna P, Liu L, Hanson AJ, Monks A and
Gerson SL: Characterization of MLH1 and MSH2 DNA mismatch repair
proteins in cell lines of the NCI anticancer drug screen. Cancer
Chemother Pharmacol. 46:507–516. 2000. View Article : Google Scholar
|
|
26
|
Kanzawa T, Germano IM, Komata T, Ito H,
Kondo Y and Kondo S: Role of autophagy in temozolomide-induced
cytotoxicity for malignant glioma cells. Cell Death Differ.
11:448–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
